// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























28841 Abstracts

Risk of Foot Ulcer and Lower Extremity Amputation among Participants in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study (DCCT/EDIC)

EDWARD J. BOYKO - American Diabetes Association (ADA) , 2018

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

N/A

N/A

NADPH Oxidase Nox5 Aggravates Renal Injury in Akita Mouse Model of Diabetic Nephropathy

JAY C. JHA - American Diabetes Association (ADA) , 2018

Therapeutic Area

Disease

Drug/Treatment

Nephrology

N/A

N/A

The Effect of Resveratrol on Reducing Neointimal Growth after Femoral Artery Injury in AMPKα2 Knockout Mice Given High-Fat Diet

LIWEI ZHOU - American Diabetes Association (ADA) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

Nitric oxide

Effect of Preadmission Diabetes Intervention (PREHAB) on Postoperative Patient Outcomes in Cardiac Surgery

AMEL ARNAOUT - American Diabetes Association (ADA) , 2018

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

N/A

N/A

Inclisiran Lowers LDL-C and PCSK9 Irrespective of Diabetes Status without Worsening Glycemia

LAWRENCE LEITER - American Diabetes Association (ADA) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

N/A

Association between Allopurinol and Cardiovascular Events and All-Cause Mortality in Diabetes—A Population-Based Cohort Study

ALANNA WEISMAN - American Diabetes Association (ADA) , 2018

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

N/A

Allopurinol

Increased Prevalence of Diabetes Mellitus after Lung Transplantation

JOSEPH M. LEUNG - American Diabetes Association (ADA) , 2018

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

N/A

N/A

On Time—An Innovative Online Discussion Tool to Overcome Barriers to Insulin Initiation

JEREMY GILBERT - American Diabetes Association (ADA) , 2018

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

N/A

Metformin Hydrochloride

Specific Deletion of PKC Delta in Endothelial Cells Restores VEGF Action in Diabetes

Pedro Geraldes - American Diabetes Association (ADA) , 2018

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

N/A

N/A

User Experience with a New Smartphone Application for Blood Glucose Monitoring (BGM) in an Information-Motivation-Behavioral Skills (IMB) Model Study

WILLIAM FISHER - American Diabetes Association (ADA) , 2018

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

N/A

N/A

Estimating Glomerular Filtration Rate Calculated by Serum Creatinine Lacks Precision and Accuracy in Adults with Type 2 Diabetes with Preserved Renal Function

JULIE A. LOVSHIN - American Diabetes Association (ADA) , 2018

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

N/A

Sitagliptin

Pancreatic Alpha-Cell Function and Identity in Human T2D

XIAOQING DAI - American Diabetes Association (ADA) , 2018

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

N/A

Intranasal glucagon

Muscarinic Receptor Antagonist Improves Nerve Fiber Function in Subjects with Type 2 Diabetes and Peripheral Neuropathy

AARON I. VINIK - American Diabetes Association (ADA) , 2018

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

N/A

Oxybutynin

Evaluation of Glomerular Hemodynamic Function by Empagliflozin in Diabetic Mice Using In Vivo Imaging

KENGO KIDOKORO - American Diabetes Association (ADA) , 2018

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

N/A

BI-10773

The Three I's of Diabetes Integration in Emerging Adulthood—Developing a Framework to Individualize Diabetes Care

BENJAMIN MARKOWITZ - American Diabetes Association (ADA) , 2018

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

N/A

N/A

Cardiovascular (CV) Safety and Severe Hypoglycemia Benefit of Insulin Degludec vs. Insulin Glargine U100 in Older Patients (=65 Years) with Type 2 Diabetes (T2D)—Observations from DEVOTE

RICHARD E. PRATLEY - American Diabetes Association (ADA) , 2018

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

N/A

Insulin glargine

Renal Outcomes in the EXenatide Study of Cardiovascular Event Lowering (EXSCEL)

M. ANGELYN BETHEL - American Diabetes Association (ADA) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Exenatide

Relationship between Weight Change Patterns and Health Satisfaction in the CANadian Canagliflozin Registry (CanCARE) Study

VINCENT C. WOO - American Diabetes Association (ADA) , 2018

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

N/A

Canagliflozin

Diagnostic Accuracy of Serologic Screening Tests for Celiac Disease in Asymptomatic Adults and Children with Type 1 Diabetes

MICHELLE GOULD - American Diabetes Association (ADA) , 2018

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

N/A

N/A

Lactobacillus Gasseri in the Upper Small Intestine Impacts an ACSL3-Dependent Fatty Acid Sensing Pathway That Regulates Whole-Body Glucose Homeostasis

PAIGE V. BAUER - American Diabetes Association (ADA) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Copyright © 2026. QuantiNova All rights reserved